Logo image of ICOP.MI

ICOP SPA (ICOP.MI) Stock Fundamental Analysis

BIT:ICOP - Euronext Milan - IT0001214433 - Common Stock - Currency: EUR

8.48  -0.88 (-9.4%)

Fundamental Rating

4

ICOP gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 40 industry peers in the Construction & Engineering industry. ICOP has an average financial health and profitability rating. ICOP has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year ICOP was profitable.
In the past year ICOP had a positive cash flow from operations.
ICOP.MI Yearly Net Income VS EBIT VS OCF VS FCFICOP.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 10M 20M 30M

1.2 Ratios

The Return On Assets of ICOP (4.54%) is better than 65.00% of its industry peers.
ICOP has a Return On Equity of 21.62%. This is in the better half of the industry: ICOP outperforms 67.50% of its industry peers.
ICOP has a Return On Invested Capital of 12.21%. This is in the better half of the industry: ICOP outperforms 72.50% of its industry peers.
ICOP had an Average Return On Invested Capital over the past 3 years of 3.66%. This is significantly below the industry average of 20.73%.
The last Return On Invested Capital (12.21%) for ICOP is above the 3 year average (3.66%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.54%
ROE 21.62%
ROIC 12.21%
ROA(3y)2.31%
ROA(5y)N/A
ROE(3y)10.4%
ROE(5y)N/A
ROIC(3y)3.66%
ROIC(5y)N/A
ICOP.MI Yearly ROA, ROE, ROICICOP.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2 4 6 8 10

1.3 Margins

ICOP has a better Profit Margin (8.37%) than 75.00% of its industry peers.
With a decent Operating Margin value of 10.32%, ICOP is doing good in the industry, outperforming 77.50% of the companies in the same industry.
The Gross Margin of ICOP (32.39%) is worse than 60.00% of its industry peers.
Industry RankSector Rank
OM 10.32%
PM (TTM) 8.37%
GM 32.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ICOP.MI Yearly Profit, Operating, Gross MarginsICOP.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 10 20 30 40 50

More info and screens

4

2. Health

2.1 Basic Checks

ICOP has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for ICOP remains at a similar level compared to 1 year ago.
Compared to 1 year ago, ICOP has an improved debt to assets ratio.
ICOP.MI Yearly Shares OutstandingICOP.MI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M 25M
ICOP.MI Yearly Total Debt VS Total AssetsICOP.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of 1.79, we must say that ICOP is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.79, ICOP perfoms like the industry average, outperforming 47.50% of the companies in the same industry.
ICOP has a debt to FCF ratio of 2.52. This is a good value and a sign of high solvency as ICOP would need 2.52 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.52, ICOP is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
ICOP has a Debt/Equity ratio of 0.66. This is a neutral value indicating ICOP is somewhat dependend on debt financing.
ICOP has a Debt to Equity ratio of 0.66. This is comparable to the rest of the industry: ICOP outperforms 47.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 2.52
Altman-Z 1.79
ROIC/WACC1.65
WACC7.4%
ICOP.MI Yearly LT Debt VS Equity VS FCFICOP.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 1.21 indicates that ICOP should not have too much problems paying its short term obligations.
ICOP has a Current ratio of 1.21. This is comparable to the rest of the industry: ICOP outperforms 57.50% of its industry peers.
ICOP has a Quick Ratio of 1.21. This is a bad value and indicates that ICOP is not financially healthy enough and could expect problems in meeting its short term obligations.
ICOP's Quick ratio of 0.91 is in line compared to the rest of the industry. ICOP outperforms 42.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.91
ICOP.MI Yearly Current Assets VS Current LiabilitesICOP.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 50M 100M

More info and screens

4

3. Growth

3.1 Past

ICOP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.95%, which is quite good.
ICOP shows a decrease in Revenue. In the last year, the revenue decreased by -0.81%.
EPS 1Y (TTM)17.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%373.67%
Revenue 1Y (TTM)-0.81%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%228.51%

3.2 Future

ICOP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 85.29% yearly.
Based on estimates for the next years, ICOP will show a very strong growth in Revenue. The Revenue will grow by 55.49% on average per year.
EPS Next Y344.19%
EPS Next 2Y150.03%
EPS Next 3Y85.29%
EPS Next 5YN/A
Revenue Next Year79.26%
Revenue Next 2Y86.09%
Revenue Next 3Y55.49%
Revenue Next 5YN/A

3.3 Evolution

ICOP.MI Yearly Revenue VS EstimatesICOP.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
ICOP.MI Yearly EPS VS EstimatesICOP.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

ICOP is valuated rather expensively with a Price/Earnings ratio of 21.74.
Compared to the rest of the industry, the Price/Earnings ratio of ICOP indicates a slightly more expensive valuation: ICOP is more expensive than 65.00% of the companies listed in the same industry.
ICOP's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 29.35.
ICOP is valuated cheaply with a Price/Forward Earnings ratio of 7.29.
ICOP's Price/Forward Earnings ratio is rather cheap when compared to the industry. ICOP is cheaper than 82.50% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.10. ICOP is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 21.74
Fwd PE 7.29
ICOP.MI Price Earnings VS Forward Price EarningsICOP.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

65.00% of the companies in the same industry are cheaper than ICOP, based on the Enterprise Value to EBITDA ratio.
62.50% of the companies in the same industry are more expensive than ICOP, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.89
EV/EBITDA 12.45
ICOP.MI Per share dataICOP.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

ICOP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ICOP's earnings are expected to grow with 85.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.06
PEG (5Y)N/A
EPS Next 2Y150.03%
EPS Next 3Y85.29%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ICOP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ICOP SPA

BIT:ICOP (3/4/2025, 7:00:00 PM)

8.48

-0.88 (-9.4%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners8.93%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap234.30M
Analysts87.5
Price Target11.88 (40.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 21.74
Fwd PE 7.29
P/S 1.85
P/FCF 8.89
P/OCF 5.06
P/B 4.78
P/tB 4.85
EV/EBITDA 12.45
EPS(TTM)0.39
EY4.6%
EPS(NY)1.16
Fwd EY13.71%
FCF(TTM)0.95
FCFY11.25%
OCF(TTM)1.68
OCFY19.77%
SpS4.58
BVpS1.77
TBVpS1.75
PEG (NY)0.06
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.54%
ROE 21.62%
ROCE 14.72%
ROIC 12.21%
ROICexc 17.24%
ROICexgc 17.44%
OM 10.32%
PM (TTM) 8.37%
GM 32.39%
FCFM 20.81%
ROA(3y)2.31%
ROA(5y)N/A
ROE(3y)10.4%
ROE(5y)N/A
ROIC(3y)3.66%
ROIC(5y)N/A
ROICexc(3y)6.27%
ROICexc(5y)N/A
ROICexgc(3y)6.36%
ROICexgc(5y)N/A
ROCE(3y)4.41%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 2.52
Debt/EBITDA 1.48
Cap/Depr 222.02%
Cap/Sales 15.78%
Interest Coverage 250
Cash Conversion 209.95%
Profit Quality 248.58%
Current Ratio 1.21
Quick Ratio 0.91
Altman-Z 1.79
F-ScoreN/A
WACC7.4%
ROIC/WACC1.65
Cap/Depr(3y)138.09%
Cap/Depr(5y)N/A
Cap/Sales(3y)10.45%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%373.67%
EPS Next Y344.19%
EPS Next 2Y150.03%
EPS Next 3Y85.29%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.81%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%228.51%
Revenue Next Year79.26%
Revenue Next 2Y86.09%
Revenue Next 3Y55.49%
Revenue Next 5YN/A
EBIT growth 1Y-64.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y589%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y507.77%
OCF growth 3YN/A
OCF growth 5YN/A